Melanoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have melanoma that has spread (stage III or IV) but where surgery was considered an option, and who have been treated with a type of immunotherapy (a treatment that helps the immune system fight cancer) before surgery was planned
- People whose immunotherapy response has been measured and confirmed, either through a tissue sample (biopsy) or through imaging scans
- People who were originally planned for surgery but did not end up having it — for example, because their cancer got worse, their cancer responded so well it could no longer be found, or they chose not to go ahead with surgery
Who may not be able to join:
- People whose melanoma started in the eye (a type called uveal melanoma)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Complete histological response
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.